Contract notice: Pharmaceutical products Tender, Denmark - 25899077

Procurement Summary

Country : Denmark

Summary : Contract notice: Pharmaceutical products

Deadline : 27 Sep 2018

Other Information

Notice Type : Tender

TOT Ref.No.: 25899077

Document Ref. No. : 357867-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AMGROS I/S
Office Name: Amgros I/S
Address: Dampfærgevej 22
Town: Copenhagen
Postal Code: 2100
Contact Point: Flemming Sonne

Phone: +45 88713000
Fax: +45 88713008
Denmark
Email :udbud@amgros.dk
URL :http://www.amgros.dk

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.

Amgros 2019-1.204.b.

Amgros is a partnership with the 5 regions as stakeholders. In order to provide stakeholders' hospital pharmacies with drugs and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I / S wishes to enter into framework agreements for the medicinal products listed in Section II.2.4. The framework agreements are non-exclusive. Amgros I / S reseller lowerthe funds to the hospital pharmacies for Amgros I / S' purchase price with an addendum. Framework agreements are entered without specification, and hospital pharmacies in the regions are not obliged to apply Amgros' framework agreements.

Main Site: Place of delivery is the address of Amgros at the address (hospital pharmacy or affiliated locations).

The tender number includes the following medicines:

Offer No: 1,

ATC Code: J01CR05,

Generic name: Piperacillin and beta-lactamase inhibitor,

Dispensing form: Powder.t.inf.s.,

Strength: 2 g 0.25 g,

Unit value: 14 g,

Quantity in units: 2 923.

Supply no.: 1,

ATC Code: J01CR05,

Generic name: Piperacillin and beta-lactamase inhibitor,

Dispensing form: Powder.t.inf.va.ke,

Strength: 4 g 500 mg,

Unit value: 14 g,

Quantity in units: 185 528.

The above medicines are offered uafhanone of the medicines listed under the other tender numbers.

Each tender number is considered a separate sub-agreement. A supplier will thus be able to bid on one or more or all tender numbers and assignment is made separately for each tender number. Reference is made to the specifications, including the submission of tenders under the individual tender numbers.

The term "quantity in units" is angiven the estimated consumption of the drugs under the tender number.

It should be noted that this amount is based on historical consumption and that suppliers may argue that actual purchases under a framework agreement may deviate significantly from that. Reference is made to the terms of the tender terms. 3.6 and the Framework Agreement Item. 2.

The medicinal product must have a marketing authorization valid for Denmark no later than 27.9.2018-pm. 12:00. Furthermore, at the time of the expiry of the deadline and during the duration of the framework agreement, the supplier shall be authorized to manufacture, import or wholesale intra-EU / EU drugs.

Suppliers who wish to submit tenders shall use the standard form for the Single European Procurement Document (ESPD) to issue a declaration regarding the obligatory exclusionsgrounds for limitation in section 135-136 of the Procurement Act (Act No. 1564 of 15 December 2015 with amendments). Further information on the completion and application of ESPD in the procurement process can be found in the instructions provided by Amgros and in the Competition and Consumer Agency's "Guide to the Single European Public Procurement Document". The winning supplier (s) that Amgros intends to award the framework agreement shall-further before the award has made documentation available to Amgros in so far as the mandatory grounds for exclusion, cf. section 152 - 153 of the Procurement Act. Amgros can not exclude a supplier who is covered by one or more of the mandatory grounds for exclusion in section 135-136 of the Public Procurement Act, safely the supplier may provide sufficient documentation that the supplier mayThe matter is palpable, cf. section 138 of the Procurement Act. Amgros reserves the right to carry out such a self-cleaning process, safely if the mat is relevant.

No information required. II.2.3 noted that a list of points of delivery is available on Amgros' Delivery and Procurement Portal, https://levportal.amgros.dk. The overview is updated on the basis of the changes.

In relation to point II.2.4 notes that Amgros has considered whether the tender group can be further subdivided. Amgros has concluded that this is not the case in the light of considerations of economies of scale that will not be realized by a further breakdown as well as costs and patient safety considerations related to the subsequent contract and drug handling.-section. II.1.5 and point II.2.6 noted that the estimated value in section. II.1.5 is the total estimated value of all tender numbers (lots) in the duration of the framework agreement incl. possibility of extension, cf. II.2.7. In section II.2.6 is the estimated value of each tender number incl. possibility of extension given, cf. II.2.7.

It is also noted that the estimated value is based on a histor consumption, and that actual purchases may therefore deviate significantly therefrom, cf. II.2.4, Item No. of the Terms and Conditions. 3.6 and the Framework Agreement Item. 2. Quotation of the tender documents must be made in the tender system, cf. the terms and conditions of the tender.

Access to tender requires that the company be established as a user of Amgros' procurement system. There may be some expeditionsage associated with user creation, and it is therefore inconceivable for any bidders to do so in good time. Reference is made to information relating to the procurement system, including the user guide. IV.2.4 notes that some parts of the offer may also be in English. Reference is made to the terms of the tender terms. 4.1.

In relation to point VI.2 noted that electronic fvaluation requirements.


Internet address (URL): http://www.amgros.dk

Documents

 Tender Notice